About StrokeDx
StrokeDx is a company based in Los Angeles (United States) founded in 2021 by Alexander Ballatori and Shane Shahrestani. StrokeDx has raised $6.7 million across 2 funding rounds from investors including DigiTx Partners and FreeFlow Ventures. StrokeDx offers products and services including Stroke Detection Device and Blood Flow Sensors. StrokeDx operates in a competitive market with competitors including Inscopix, Darmiyan, Artiria, RetiSpec and VISIE, among others.
- Headquarter Los Angeles, United States
- Founders Alexander Ballatori, Shane Shahrestani
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Strokedx, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.7 M (USD)
in 2 rounds
-
Latest Funding Round
$5 M (USD), Seed
May 23, 2024
-
Investors
DigiTx Partners
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of StrokeDx
StrokeDx offers a comprehensive portfolio of products and services, including Stroke Detection Device and Blood Flow Sensors.
Portable tool for rapid stroke detection to enable timely treatment.
Sensors that monitor brain blood flow for early stroke indicators.
People of StrokeDx
Unlock access to complete
Unlock access to complete
Funding Insights of StrokeDx
StrokeDx has successfully raised a total of $6.7M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $5 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in StrokeDx
StrokeDx has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include DigiTx Partners and FreeFlow Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage digital health companies are supported through venture capital investments.
|
Locked | Locked | Locked | |
|
Tech startups are accelerated and incubated by FreeFlow.
|
Locked | Locked | Locked |
Investor details for StrokeDx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by StrokeDx
Investment portfolio details for StrokeDx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - StrokeDx
Detailed financials for StrokeDx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Strokedx Comparisons
Peer comparison for StrokeDx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of StrokeDx
StrokeDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inscopix, Darmiyan, Artiria, RetiSpec and VISIE, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Miniscope platforms are developed for decoding brain neural circuits.
|
|
| Locked | Locked | Locked |
Platform for presymptomatic diagnosis of neurodegenerative disorders
|
|
| Locked | Locked | Locked |
Micro-navigation systems for stroke surgery are developed.
|
|
| Locked | Locked | Locked |
Non-invasive eye scanner for early Alzheimer’s detection is developed.
|
|
| Locked | Locked | Locked |
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery
|
Detailed competitors of StrokeDx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Strokedx
Complete news archive for StrokeDx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about StrokeDx
StrokeDx was founded in 2021 and raised its 1st funding round 1 year after it was founded.
StrokeDx is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Alexander Ballatori is the current CEO of StrokeDx. They have also founded this company.
StrokeDx is a funded company, having raised a total of $6.7M across 2 funding rounds to date.
StrokeDx was founded in 2021 and is based in Los Angeles, United States. Operations focus on the medical technology sector, where a portable diagnostic device for stroke is being developed. Next-generation technology is employed to continuously collect data on blood flow through the brain, aiding in timely diagnosis. The team includes co-founders Alexander Ballatori as CEO and Shane Shahrestani.
StrokeDx offers Stroke Detection Device and Blood Flow Sensors.
StrokeDx has 2 investors. Key investors include DigiTx Partners, and FreeFlow Ventures.